Aktuelles

Legal proceedings started against patents on human embryonic stem cells and interventions in the human germ line

Case brought before the German Federal patent court and opposition filed at European Patent Office
Thursday, 20 February 2020

Testbiotech has started legal proceedings in two cases against patents. The cases were initiated to clarify fundamental ethical questions in patent law, especially in regard to the protection of human dignity. A case was filed at the German Federal patent court (Bundespatentgericht) in a bid to nullify the German patent (DE102004062184), which claims uses of human embryos to obtain stem cells.

Risks of genetically engineered plants: A wake-up call

Results of an international research project to be presented in Berlin
Thursday, 16 January 2020

The results of an international research project will be presented today in Berlin. The RAGES project (Risk Assessment of genetically engineered organisms in the EU and Switzerland) started in 2016; it investigated in detail the approval processes for genetically engineered plants. The project is completely independent of the interests of the biotechnology industry. Results from the RAGES project show that risk assessors in the EU and Switzerland have failed, and are still failing, to deal with the risks to public health and the environment.

Pages

Alle | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009